Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cell Death & Disease|August 26, 2020
The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXAAlina Muenchow, Sandra Weller, Clemens Hinterleitner, et al.
Frontiers in Immunology|September 28, 2020
Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic LeukemiaMelanie Märklin, Alexander R Fuchs, Claudia Tandler, et al.
Blood|September 25, 2003
Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cellsSilke Appel, Andreas M Boehmler, Frank Grünebach, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2012
Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cellsMartin Vaeth, Ulrike Schliesser, Gerd Müller, et al.
Cancer Research|February 12, 2004
Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysisSusanne M Schmidt, Kerstin Schag, Martin R Müller, et al.
Cancer Research|June 3, 2006
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patientsJan Wierecky, Martin R Müller, Stefan Wirths, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2009
Requirement for balanced Ca/NFAT signaling in hematopoietic and embryonic developmentMartin R Müller, Yoshiteru Sasaki, Irena Stevanovic, et al.
Journal of Leukocyte Biology|December 18, 2018
Loss of NFAT2 expression results in the acceleration of clonal evolution in chronic lymphocytic leukemiaDavid J Müller, Stefan Wirths, Alexander R Fuchs, et al.
Stem Cells Translational Medicine|January 4, 2013
Shared cell surface marker expression in mesenchymal stem cells and adult sarcomasStefan Wirths, Elke Malenke, Torsten Kluba, et al.
Cancer Immunology, Immunotherapy : CII|February 23, 2018
The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cellsDaniela Dörfel, Christian J Lechner, Simone Joas, et al.
Pageof 5